JENBURKT PHARMACEUTICAL L Latest Share Price (JENBURPH)
TODAY IN ONE LINE
JENBURPH edged up 0.8%, in line with Nifty's 0.0% move.
it trades at a P/E of N/A. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
JENBURKT PHARMACEUTICAL L flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Steady Dividend YieldReliable 2.13% dividend yield
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Sales ContractionQuarterly sales dropped 20.4% YoY
Latest JENBURKT PHARMACEUTICAL L News
What changed recently?
Recent events, corporate actions, and announcements.
JENBURKT PHARMACEUTICAL L valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for JENBURKT PHARMACEUTICAL L, framed against the sector median so the premium or discount is obvious at a glance.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
JENBURKT PHARMACEUTICAL L technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for JENBURKT PHARMACEUTICAL L — derived from the latest tape, not yesterday's close.
JENBURKT PHARMACEUTICAL L last traded at ₹1,000.1 with an intraday range of ₹1,000–₹1,009.7 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹1000.10| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 1025.93 | +25.83 | +2.58% |
| R3 | 1016.23 | +16.13 | +1.61% |
| R2 | 1012.97 | +12.87 | +1.29% |
| R1 | 1006.53 | +6.43 | +0.64% |
| PIVOT | 1003.27 | 3.17 | 0.32% |
| CURRENT | 1000.10 | — | — |
| S1 | 996.83 | -3.27 | -0.33% |
| S2 | 993.57 | -6.53 | -0.65% |
| S3 | 987.13 | -12.97 | -1.30% |
| S4 | 977.43 | -22.67 | -2.27% |
JENBURPH is trading Below CPR, indicating Bearishness
CPR is Average
Day's range: ₹1007–₹1009.7
Trading Above opening range, showing Bullishness
JENBURKT PHARMACEUTICAL L financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for JENBURKT PHARMACEUTICAL L — consolidated or standalone — with margins, YoY growth and key ratios inline.
JENBURKT PHARMACEUTICAL L reports its full P&L, balance sheet, cash flow and ratios on this page — current reported EPS of ₹13.34.
JENBURKT PHARMACEUTICAL L segment analysis : revenue and profit mix.
Disclosed business segments at JENBURKT PHARMACEUTICAL L with their share of revenue and profit, switchable between consolidated and standalone reporting.
JENBURKT PHARMACEUTICAL L discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for JENBURKT PHARMACEUTICAL L.
Our AI distills the core fundamental drivers supporting JENBURKT PHARMACEUTICAL L, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
What you're getting.
No strengths or opportunities on record.
Key Risks.
No weaknesses or threats on record.
Flip Conditions.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Income thesis breaks if the dividend is cut or yield falls below 1.06%.
JENBURKT PHARMACEUTICAL L peer comparison — same-sector benchmarks.
No comparable peer set was disclosed for JENBURKT PHARMACEUTICAL L.
Peer comparison data is not available.
JENBURKT PHARMACEUTICAL L chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for JENBURKT PHARMACEUTICAL L — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
JENBURKT PHARMACEUTICAL L delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for JENBURKT PHARMACEUTICAL L over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in JENBURKT PHARMACEUTICAL L stood at 82.8% of traded volume, against a 20-day average of 87.1%.
JENBURKT PHARMACEUTICAL L announcements: results, concalls, ratings, M&A.
Filings JENBURKT PHARMACEUTICAL L sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
JENBURKT PHARMACEUTICAL L files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 22 documents below.
Company Update
Re-Appointment of Shri. Dilip H. Bhuta (DIN 01357252) as Whole Time Director and CFO of the Company for the Period of 05 years from 01st April, 2027…
AGM/EGM
Submission of consolidated Voting Results and Scrutinizer''s Report on all the Resolutions as set out in the Notice Convening the 41st AGM of the…
Company Update
Proceedings of the 41st Annual General Meeting of the Company held on Friday, 04th September, 2026.
AGM/EGM
Summary of the proceedings of the 41st Annual General Meeting of the Company held on Friday, 04th September, 2026.
Company Update
Pursuant to Regulation 30 Read with Schedule III of the SEBI(Listing Obligations and Disclosure Requirnments ) Regulations 2015, we hereby inform you…
JENBURKT PHARMACEUTICAL L dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue JENBURKT PHARMACEUTICAL L has declared, sequenced by announce and record date.
JENBURKT PHARMACEUTICAL L corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About JENBURKT PHARMACEUTICAL L: business, sector, key facts.
What JENBURKT PHARMACEUTICAL L does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
JENBURKT PHARMACEUTICAL L is a listed Indian equity.
JENBURKT PHARMACEUTICAL L
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Stocks near 52-week low (reversal watch)Screener
- Reversal Hunter strategy playbookStrategy
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about JENBURKT PHARMACEUTICAL L (JENBURPH).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of JENBURKT PHARMACEUTICAL L (JENBURPH)?
The current share price of JENBURKT PHARMACEUTICAL L (JENBURPH) is ₹1,000.10. Today, the stock has gained by ₹8.10 (0.82%), trading in a range of ₹1,000.00 to ₹1,009.70. The stock opened at ₹1,007.00 with a trading volume of 187 shares.
02What is the 52-week high and low price of JENBURKT PHARMACEUTICAL L stock?
The 52-week high price of JENBURKT PHARMACEUTICAL L (JENBURPH) is ₹1,073.90, while the 52-week low is ₹960.30. Currently trading at ₹1,000.10, the stock is 4.14% above its 52-week low and 6.87% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
03What is the dividend yield of JENBURKT PHARMACEUTICAL L and when is the next dividend?
JENBURKT PHARMACEUTICAL L offers a dividend yield of 2.13%, which means for every ₹100 invested at the current price of ₹1,000.10, you can expect to receive approximately ₹2.13 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
04How is JENBURKT PHARMACEUTICAL L stock performing today in the market?
JENBURKT PHARMACEUTICAL L stock opened at ₹1,007.00 and is currently trading at ₹1,000.10, showing a gain of ₹8.10 (0.82%). The intraday high is ₹1,009.70 and low is ₹1,000.00. The trading volume stands at 187 shares, indicating moderate market participation today.
05What is the market capitalization of JENBURKT PHARMACEUTICAL L?
JENBURKT PHARMACEUTICAL L has a market capitalization of ₹0, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹1,000.10) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
06What is the ROE and ROCE of JENBURKT PHARMACEUTICAL L?
JENBURKT PHARMACEUTICAL L has a Return on Equity (ROE) of 0% and Return on Capital Employed (ROCE) of 0%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
07Which sector and industry does JENBURKT PHARMACEUTICAL L belong to?
JENBURKT PHARMACEUTICAL L operates in the broader sector and belongs to the its industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
08What is the sales and profit growth of JENBURKT PHARMACEUTICAL L?
JENBURKT PHARMACEUTICAL L has reported a sales growth of 0% and profit growth of -45.75%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
The data, ratios and commentary about JENBURKT PHARMACEUTICAL L (JENBURPH) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.